mTORC1 and mTORC2 play different roles in regulating cardiomyocyte differentiation from embryonic stem cells

Bei Zheng1, Jiadan Wang, Leilei Tang

  • 1Institute of Pharmacology and Toxicology, Zhejiang University, Hangzhou, China.

Insights

Mammalian target of rapamycin complex 2 (mTORC2) activation is critical for cardiomyocyte differentiation from mouse embryonic stem cells. mTORC1 inhibition enhances this process by upregulating mTORC2 signaling.

Area of Science:

  • Cell Biology
  • Developmental Biology
  • Stem Cell Research

Background:

  • Mammalian target of rapamycin (mTOR) signaling pathways, specifically mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), are vital for cellular survival and growth.
  • The precise roles of mTORC1 and mTORC2 in regulating cardiomyocyte differentiation from mouse embryonic stem cells (mESCs) remain largely undefined.

Purpose of the Study:

  • To elucidate the distinct functions of mTORC1 and mTORC2 in directing cardiomyocyte differentiation from mESCs.
  • To investigate the interplay between mTORC1 and mTORC2 during this differentiation process.

Main Methods:

  • Knockdown experiments targeting Raptor (mTORC1 component) and Rictor (mTORC2 component) in mESCs.
  • Quantitative analysis of cardiomyocyte differentiation markers and myofilament organization.
  • Assessment of protein phosphorylation levels, specifically Rictor phosphorylation at Thr1135.

Main Results:

  • Raptor ablation significantly enhanced cardiomyocyte differentiation, increasing the number of cells with organized myofilaments and upregulating cardiac markers (brachyury, Nkx2.5, α-Actinin).
  • Rictor loss impaired cardiomyocyte differentiation, and dual ablation of Raptor and Rictor reduced cardiomyocyte numbers.
  • Knockdown of Raptor/mTORC1 led to decreased Rictor phosphorylation, consequently activating Rictor/mTORC2 signaling and promoting mESC differentiation into cardiomyocytes.

Conclusions:

  • mTORC1 and mTORC2 exhibit opposing roles in mESC-derived cardiomyocyte differentiation.
  • Activation of Rictor/mTORC2 is essential for facilitating cardiomyocyte differentiation.
  • Targeting mTORC2 presents a potential strategy for regulating myocardial differentiation from stem cells.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K